Vascular age: Integrating carotid intima‐media thickness measurements with global coronary risk assessment

医学 列线图 弗雷明翰风险评分 内科学 内膜中层厚度 心脏病学 风险评估 血压 人口 颈动脉 疾病 计算机安全 计算机科学 环境卫生
作者
James H. Stein,Michael C. Fraizer,Susan E. Aeschlimann,Jane Nelson‐Worel,Patrick E. McBride,Pamela S. Douglas
出处
期刊:Clinical Cardiology [Wiley]
卷期号:27 (7): 388-392 被引量:156
标识
DOI:10.1002/clc.4960270704
摘要

An imaging test that quantifies atherosclerotic burden and that can be integrated with existing risk stratification paradigms would be a very useful clinical tool.Measurement of carotid intima-media thickness (CIMT) is feasible in a clinical setting. Such measurements can be integrated into coronary risk assessment models.Carotid intima-media thickness was measured by B-mode ultrasound in 82 consecutive patients without manifest atherosclerotic vascular disease. The values were used to determine "vascular age" (VA) based on nomograms from the Atherosclerosis Risk in Communities study. Vascular age was substituted for chronological age and standard and vascular age-adjusted 10-year coronary heart disease (CHD) risk estimates were compared.The mean chronological age was 55.8 +/- 9.0 years. The mean VA using CIMT was 65.5 +/- 18.9 years (p < 0.001). The Framingham 10-year hard CHD risk estimate was 6.5 +/- 4.9%. Substituting CIMT-derived VA for chronological age increased the 10-year CHD risk estimate to 8.0 +/- 6.8% (p < 0.001). Of 14 subjects initially at intermediate risk, 5 (35.7%) were reclassified as higher risk and 2 (14.3%) were reclassified as lower risk. Significant predictors of reclassification were tobacco use, high-density lipoprotein cholesterol, systolic blood pressure, and low-density lipoprotein cholesterol.Measurement of CIMT, a noninvasive estimate of current atherosclerotic burden, is feasible in a clinical setting and can be integrated into CHD risk assessment models. Determining VA using CIMT values may help individualize the age component of population-based CHD risk estimates. This strategy should be tested in a large trial with hard clinical endpoints.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
柳大宝发布了新的文献求助10
2秒前
www完成签到 ,获得积分10
2秒前
2秒前
阿克完成签到,获得积分20
3秒前
sympurity发布了新的文献求助10
3秒前
李菠萝发布了新的文献求助10
3秒前
4秒前
亚李完成签到 ,获得积分10
4秒前
5秒前
ZZZ发布了新的文献求助10
5秒前
阿克发布了新的文献求助10
6秒前
xin完成签到,获得积分10
6秒前
KD发布了新的文献求助10
6秒前
Tigher完成签到,获得积分10
6秒前
da_line发布了新的文献求助10
6秒前
我是老大应助zjx采纳,获得10
7秒前
YHT完成签到,获得积分10
7秒前
8秒前
8秒前
xunpeng完成签到,获得积分10
10秒前
10秒前
斯文败类应助柳大宝采纳,获得10
11秒前
KD完成签到,获得积分10
12秒前
李子发布了新的文献求助10
13秒前
xunpeng发布了新的文献求助10
13秒前
15秒前
FashionBoy应助科研通管家采纳,获得10
15秒前
乐观小之应助科研通管家采纳,获得10
15秒前
8R60d8应助科研通管家采纳,获得10
15秒前
8R60d8应助科研通管家采纳,获得30
15秒前
SYLH应助科研通管家采纳,获得10
15秒前
丘比特应助科研通管家采纳,获得10
15秒前
SYLH应助科研通管家采纳,获得10
15秒前
LaTeXer应助科研通管家采纳,获得10
15秒前
LaTeXer应助科研通管家采纳,获得10
15秒前
打打应助科研通管家采纳,获得10
15秒前
8R60d8应助科研通管家采纳,获得10
15秒前
顾矜应助科研通管家采纳,获得10
16秒前
8R60d8应助科研通管家采纳,获得10
16秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
Interpretation of Mass Spectra, Fourth Edition 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3956458
求助须知:如何正确求助?哪些是违规求助? 3502597
关于积分的说明 11109039
捐赠科研通 3233376
什么是DOI,文献DOI怎么找? 1787315
邀请新用户注册赠送积分活动 870585
科研通“疑难数据库(出版商)”最低求助积分说明 802122